Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial | Zendy

Patrick Sawa | Zendy; Seif Shekalaghe | Zendy; Chris Drakeley | Zendy; Colin J. Sutherland | Zendy; Collins K. Mweresa | Zendy; Amrish Baidjoe | Zendy; Alphaxard Manjurano | Zendy; Reginald A. Kavishe | Zendy; Khalid B. Beshir | Zendy; Rahma U. Yussuf | Zendy; Sabah A. Omar | Zendy; Cornelus C. Hermsen | Zendy; Lucy Okell | Zendy; Henk D. F. H. Schallig | Zendy; Robert W. Sauerwein | Zendy; Rachel Hallett | Zendy; Teun Bousema | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial

Author(s) -

Patrick Sawa,

Seif Shekalaghe,

Chris Drakeley,

Colin J. Sutherland,

Collins K. Mweresa,

Amrish Baidjoe,

Alphaxard Manjurano,

Reginald A. Kavishe,

Khalid B. Beshir,

Rahma U. Yussuf,

Sabah A. Omar,

Cornelus C. Hermsen,

Lucy Okell,

Henk D. F. H. Schallig,

Robert W. Sauerwein,

Rachel Hallett,

Teun Bousema

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit077

Subject(s) - artemether/lumefantrine , gametocyte , malaria , artemisinin , medicine , parasitemia , piperaquine , confidence interval , randomized controlled trial , plasmodium falciparum , dihydroartemisinin , immunology

Artemisinin-based combination therapy (ACT) reduces the potential for malaria transmission, compared with non-ACTs. It is unclear whether this effect differs between ACTs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research